Physician profile
John E Cochran
NPI 1447666482
$847.00
in general payments reported to CMS, 2019-2025
16 companies · $49.95 in 2025
The $49.95 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $157 · 2021: $67.23 · 2022: $68.75 · 2024: $113 · 2025: $49.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113 · Long Term Medical Supply Or Device Loan: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.52 |
| Long Term Medical Supply Or Device Loan | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.96 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $125.88 | 2019-2022 | |
| Biosense Webster, INC. | $112.52 | 2024 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $106.36 | 2019-2022 | |
| Abbott Laboratories | $49.95 | 2025 | Freestyle Insulinx |
| Novo Nordisk INC | $45.07 | 2019 | |
| Amgen INC. | $34.42 | 2019 | |
| Astellas Pharma US INC | $30.91 | 2019-2020 | |
| Lilly USA, LLC | $27.14 | 2019-2021 | |
| Pfizer INC. | $24.69 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $21.67 | 2020 | |
| Allergan, INC. | $17.49 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.40 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $12.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.34 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $1.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cochran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.